Decline depth
-26.6%
From rolling 252-day high of $39.28, 127d ago.
Past the 20% Watch threshold.
-26.6%
from rolling 252-day high of $39.28 set 2026-01-07 · 127d ago
Current
$28.84
Decline depth
-26.6%
Decline σ
7.2σ
TFC
2/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Structural break signals
IDYA qualifies for the Amber List on decline depth.
Time-frame continuity
2/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
7.2σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (2.54% per day).
Past the ≥6σ Amber threshold.
The structural read
What price action says about IDYA.
IDYA qualifies for the Amber List on decline depth — down -26.6% from its rolling 252-day high.
Cross-confirmation: decline sigma also reads 7.2σ over 20 bars.
Upstream TFC read: weak alignment, current phase weekly. Last bar types — daily 2U (red), weekly 3 (green), monthly 2D (red).
Earnings on file: 2026-05-05. Tiering is unaffected by earnings dates — listings reflect price structure only.
52-week range
52W low $16.84
53.5% of range
52W high $39.28
Sector context · Healthcare
182 other Healthcare tickers are on Broken Stocks.
93
Red List
42
Amber
47
Watch
-35.8%
Median decline
Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →
Related — same sector
Closest decliners to IDYA
Red List Recovering
CHE
Chemed Corp
Watch Recovering
VKTX
Viking Therapeutics, Inc.
Amber List Recovering
MDT
Medtronic plc.
Watch Recovering
DYN
Dyne Therapeutics, Inc.
Amber List
NEOG
Neogen Corporation
Watch
CAPR
Capricor Therapeutics, Inc.
Questions about IDYA
What people ask.
Why is IDYA on Broken Stocks?
IDYA qualifies for the Amber List on decline depth. It is down -26.6% from its rolling 252-day high of $39.28, set on 2026-01-07 — 127d ago.
Is IDYA a falling knife?
No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. IDYA is down -26.6% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.
Is IDYA a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is IDYA trading inside its 52-week range?
At $28.84, IDYA sits 53.5% of the way from its 52-week low ($16.84) to its 52-week high ($39.28). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has IDYA been declining?
The current 26.6% decline accrued over 127d, which annualizes to roughly -76.4% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does IDYA compare to its sector?
There are 182 other Healthcare tickers on Broken Stocks: 93 Red, 42 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — IDYA's decline is shallower than the sector median.
Does IDYA's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.